Telix Completes Acquisition of Atlab for Prostate Cancer Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. SPY
2. USO
3. NET
4. ORCL
5. SPCX
6. SJM
7. SAIL
8. ETR
9. AMZN
10. HUMA

Go back to Telix Completes Acquisition of Atlab for Prostate Cancer Program
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 9.44 +0.03 (0.32%)
Previous Close $9.41    52 Week High $2.18 
Open $9.38    52 Week Low $0.30 
Day High $9.60    P/E N/A 
Day Low $9.30    EPS $-3.32 
Volume 94,875